{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f61e5b80af9f547701a9bd7/613b5d1f8c635e0014eb7b3f?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"How is precision medicine transforming cancer care?","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5f61e5b80af9f547701a9bd7/1631280092140-2f25ff60a1179b75273d21e93fafff8e.jpeg?height=200","description":"<p>Welcome to 19 Conversations. Today we're asking Dr Dominik Mumberg, Translational Innovation Lead, Bayer and Dr Mathias Rossberg, VP, Business Unit Head, Oncology &amp; Haematology, Bayer \"How is precision medicine transforming cancer care?\". Listen to hear their discussion on the challenge and how we're preparing for the future.</p>","author_name":"EFPIA"}